Navigation Links
SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
Date:10/24/2008

FLAGSTAFF, Ariz., Oct. 24 /PRNewswire/ -- SenesTech, Inc. has initiated field trials of its platform technology on the Indonesian island of Java in continuing research collaboration with international partners.

After meeting with Dr. Grant Singleton of the International Rice Research Institute in Manila, Philippines, Drs. Loretta Mayer and Cheryl Dyer of SenesTech, Inc. will join Dr. Lyn Hinds of the Australian Commonwealth Scientific and Industrial Research Organisation (CSIRO) and Dr. Sudarmaji of the Indonesian Rice Research Council (IRRC) at the field testing site of the IRRC in Sukamundi, Java. The group will initiate the first field trials of the active ingredient in ContraPest(R). This 21st century alternative to rat poison will be used to cause permanent reproductive failure in female rice field rats (Rattus argentiventer).

The environmentally neutral active ingredient in ContraPest(R) targets the ovaries of female rats, and selectively destroys early-stage egg cells. When these cells become inactive after exposure to ContraPest(R), they cannot mature, the animal can no longer ovulate, and the effect on rodent pest populations can be dramatic. These rodent pests can eat or damage up to 50% of a rice crop in Southeast Asia. Just a 10% increase in crop yield due to less rodent damage will result in feeding up to 380 million more people per year.

"Field testing in the agricultural environment where ContraPest(R) will be applied is a significant step forward in our product development process," said Everett Hale, CEO of SenesTech, Inc. "Collecting data from the rice fields on our first target species gives us the right information to design the best product possible."

Field trials with the rice fields on Java coincide with the annual rice planting and harvesting cycles. SenesTech, Inc. and its partners are planning more field testing in March and April 2009.

For additional information contact Everett Hale at

SOURCE SenesTech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
2. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
3. Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine
4. Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors
5. CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases
6. NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
7. Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
8. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
9. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
10. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
11. Nuvelo Initiates Phase 1 Clinical Trial of NU206 in Healthy Volunteers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... and recognized refractive and cataract surgery ex...t their fellow surgeons up-to-date on the latest d... surgery, and ophthalmology in general at the rece...AAO) annual meeting in San Francisco, California. ...id Huang, MD, Dr. Randy Epstein, Dr. William Tratt...
(Date:11/18/2009)...ndards and Technology (NIST) has demonstrated a re...and measuring elusive hazards such as concealed ex... pesticides distributed in soil by wind and rain. ...tional techniques for detecting traces of these ma...ng distinct electrically positive and negative end...
(Date:11/18/2009)...nalysis combined with Bio-Rad,s Biotechnology ...rovide state-of-the-art solutions to biotechnology...swire/ -- Vernier Software & Technology, a pro...and software and Bio-Rad Laboratories, Inc., a mul...ience research and clinical diagnostics products t...
(Date:11/18/2009)...n and SwitchGear Genomics announce a novel method ... Madison, WI, USA (PRWEB) Nov...ar Genomics announce a novel method for characteri...using the HaloCHIP™ System and high-throughp...elate DNA binding events to transcriptional activa...
Breaking Biology Technology:Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Prototype NIST method detects and measures elusive hazards 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2
...The Future Strategies of Cervical Cancer Preventio...cilitates Discussion on the Prevention of Cervical..., CHICAGO, Sept. 9 The Society of Gynecologic On...ntion Forum on September 12-13,2008 at the Hotel S...aders,will be in attendance to discuss the undefin...
...ETHLEHEM, Pa., Sept. 9 A seven and a half-year st...oom Laboratory of the Lehigh,Valley Hospital and H...or,"UVC" lights installed in the HVAC system had a...cy rates (CPR). In presenting the findings at the,...ctive Medicine (ASRM),Kathryn C. Worrilow, Ph.D. r...
...ybritech Alumni Launched the World,s 3rd Largest B...han 175 Local Companies, SAN DIEGO, Sept. 9 The ...th Anniversary Reunion for Hybritech employees wil...the headquarters of AMN,Healthcare in San Diego., ...ddy" biotech company,began operations in temporary...
Other Biology Technology:Society of Gynecologic Oncologists to Host Cervical Cancer Prevention Forum 2Society of Gynecologic Oncologists to Host Cervical Cancer Prevention Forum 3Germicidal UVC Lights Improve Clinical Pregnancy Rates for IVF Lab, New Study Finds 2San Diego's Original Biotech Company Celebrates 30th Anniversary With Reunion 2
(Date:11/20/2009)... 19, 2009 The estimated 4.6 million Americans inv...eloping respiratory symptoms due to poor air quali...udy undertaken earlier this year by investigators ...y Medicine. , The studywhich polled more than 80...nt of individuals working in barns complained of c...
(Date:11/20/2009)... German . , In the current online issue of t...ie Eyerich and Dr. Kilian Eyerich together with th...tituto Dermopatico dell,Immacolata in Rome, presen...milestone on the way to developing new treatment m...iasis and allergic reactions and potentially also ...
(Date:11/20/2009)...y, researchers report that a class of heart medica...harmful, effect on the heart, depending on their m... the journal Circulation Research , found that be...eceptors on the heart muscle offer the most benefi...y the beta-receptors can actually undermine the st...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211 a Novel Product Candidate for the Treatment of Respiratory Diseases 50392 1Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211 a Novel Product Candidate for the Treatment of Respiratory Diseases 50392 2Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 1Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 2Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 3Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 4Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 5Huge Potential Returns for Healthcare Innovators 50385 1
... drug seems very promising on paper; things are,of...omerase inhibitors,to treat cancer; they are suppo...nitely) aspect of cancer cells. Yet, something in ... them to inhibit completely,the telomerase. What t...lse? Hell no! Look out for whats stopping the drug...
... with E.coli, can lead to urinary tract infections... , “We found out that UTIs may be caused by inges...bRoy, director of Penn State’s Gastroenteric Disea...ed, she noted. , Senior author, Dr. Lee W. Riley,...oli strains isolated from patients with UTIs were ...
...tory earlier ;,progress in this area is made in th...eding the slow (and tedious) process of gene,cloni...c). ,Devices the size of a pager now have greater ...entire room. Similar advances are being,made in th...rsity of,Houston, now allowing researchers to inex...
Other Biology News:Combination therapy boosts effectiveness of telomere-directed cancer cell death 2Bacteria collection sheds light on urinary tract infections 2Inexpensive, mass-produced genes core of synthetic biology advances at UH 2
Rat siTrio from B-Bridge International
Human siTrio from B-Bridge International
Rat siTrio from B-Bridge International
...convenience from the former kit #17295. However, t... but also produced some advantages as follows. At ...ugated antibody from lyophilized product to liquid... conjugate has improved so that the conjugate can ...
Biology Products: